China Health Technology Group Holding Company Limited
CHBOF
$0.04
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 107.05% | 104.07% | 64.19% | 65.50% | -22.51% |
| Total Other Revenue | -- | -- | -- | -- | -98.09% |
| Total Revenue | 107.05% | 104.07% | 64.19% | 65.50% | -22.51% |
| Cost of Revenue | 76.52% | 73.97% | 86.35% | 87.83% | 0.70% |
| Gross Profit | 392.53% | 388.35% | -25.83% | -25.21% | -127.96% |
| SG&A Expenses | -49.41% | -50.13% | 5.96% | 6.80% | -4.15% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 37.14% | 35.16% | 56.45% | 57.70% | -0.87% |
| Operating Income | 90.04% | 90.18% | -28.58% | -29.64% | -101.52% |
| Income Before Tax | 1,383.28% | 1,365.30% | -97.49% | -97.47% | 83.30% |
| Income Tax Expenses | 5,700.00% | 5,666.67% | 4,300.00% | 4,400.00% | -99.71% |
| Earnings from Continuing Operations | 1,361.52% | 1,342.61% | -97.52% | -97.50% | 85.75% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1,361.52% | 1,342.61% | -97.52% | -97.50% | 85.75% |
| EBIT | 90.04% | 90.18% | -28.58% | -29.64% | -101.52% |
| EBITDA | 90.83% | 90.95% | -28.00% | -29.03% | -99.20% |
| EPS Basic | 1,121.43% | 1,114.29% | -98.02% | -98.02% | 97.74% |
| Normalized Basic EPS | 84.73% | 85.61% | -12.82% | -15.38% | 92.76% |
| EPS Diluted | 1,121.43% | 1,114.29% | -98.02% | -98.02% | 97.74% |
| Normalized Diluted EPS | 84.73% | 85.61% | -12.82% | -15.38% | 92.76% |
| Average Basic Shares Outstanding | 20.01% | 20.01% | 26.32% | 26.32% | 549.04% |
| Average Diluted Shares Outstanding | 20.01% | 20.01% | 26.32% | 26.32% | 549.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |